The FDA may be about to change everything for peptide research. Secretary RFK Jr. announced plans to move 14 peptides from Category 2 to Category 1. That means FDA recognized. Potentially prescribable through Best Way to Take BPC 157: Dosage & Administration of the Federal Food, Drug, and Cosmetic Act (FDCA).* Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # Peptides Are Legal. Here's What Actually Matters Now. COP FDA Removes BPC 157, TB 500 and 10 More Peptides from Category 2 (April 2026)